newsfilter
← Latest News
Business Wire·

Cybin Announces $175 Million Registered Direct Offering

- Funding of Clinical Stage Programs with Participation from Prominent Biotech Investors - - Use of Proceeds Includes Repayment of High Trail Convertible Note in Full - Cybin Inc. (Cboe CA: CYBN) (NYSE:CYBN)